Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04945863Completed

COVID-19 in Nursing Homes 2020 and 2021

Role: lead

NCT03357393Not ApplicableCompleted

Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy

Role: lead

NCT02026687Phase 4Completed

Recovery and Analgesia After Surgery for Gynecological Cancer

Role: lead

NCT01458678Not ApplicableCompleted

Non Invasive Methods to Guide Volume Optimization

Role: lead

All 4 trials loaded